EUDA Health Holdings EUDA
NASDAQ EUDA
$12.73 -2.27 (-13.14%)
As of: Aug 21, 2026 · 9:46 AM EDT

EUDA Health Holdings Ltd (EUDA) Return on Sales (2022 - 2023)

EUDA Health Holdings (EUDA) posted quarterly Return on Sales of 0.46% for Q2 2023, down 45.0% year-over-year from 0.83% in Q2 2022, and down 3125.1% quarter-over-quarter from 0.01% in Q1 2023.

EUDA Health Holdings Ltd (EUDA) Return on Sales (2022 - 2023) Analysis & Trends

EUDA Health Holdings (EUDA) has reported Return on Sales for 2 consecutive years, with 0.46% the latest figure, recorded in Q2 2023.

  • In Q2 2023, Return on Sales fell 45.0% year-over-year to 0.46%; the TTM figure through Jun 2023 stood at 0.03% (changed N/A YoY), while the FY2025 annual figure was 0.0%, down 1.0% from the prior year.
  • Return on Sales fell to 0.46% in Q2 2023 per EUDA's latest filing, from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.0% in Q1 2022 and bottomed at 0.46% in Q2 2023.

Peer Comparison

Historic Data

Download Data
DateValue
Jun 30, 2023 -0.46%
Mar 31, 2023 -0.01%
Jun 30, 2022 -0.01%
Mar 31, 2022 0.00%